Every 13F-reported equity position this quarter with its quarter-over-quarter change; each row traces to the filer's 13F-HR on EDGAR.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR
Every 13F-reported equity position this quarter with its quarter-over-quarter change; each row traces to the filer's 13F-HR on EDGAR.
Tamarack Advisers, LP (CIK 1661462) reported $2.1M across 1 reported positions in its SEC 13F filing for 2023-12-31. Largest positions: STRM ($2.1M, 100.00%), ANGO ($0, 0.00%), ATRC ($0, 0.00%), BDX ($0, 0.00%), BDXB ($0, 0.00%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | STRM | STREAMLINE HEALTH SOLUTIONS ORD | $2.1M | 100.00% | 4.9M | Hold |
| 2 | ANGO | ANGIODYNAMICS ORD | $0 | 0.00% | 0 | Exited |
| 3 | ATRC | ATRICURE ORD | $0 | 0.00% | 0 | Exited |
| 4 | BDX | BECTON DICKINSON ORD | $0 | 0.00% | 0 | Exited |
| 5 | BDXB | BDX Oct3 275.0 C | $0 | 0.00% | 0 | Exited |
| 6 | CERS | CERUS ORD | $0 | 0.00% | 0 | Exited |
| 7 | COLL | COLLEGIUM PHARMACEUTICAL ORD | $0 | 0.00% | 0 | Exited |
| 8 | DXCM | DXCM Oct3 110.0C | $0 | 0.00% | 0 | Exited |
| 9 | MCK | MCKESSON ORD | $0 | 0.00% | 0 | Exited |
| 10 | MDRX | VERADIGM ORD | $0 | 0.00% | 0 | Exited |
| 11 | PHR | PHREESIA ORD | $0 | 0.00% | 0 | Exited |
| 12 | SIBN | SI BONE ORD | $0 | 0.00% | 0 | Exited |
| 13 | SNY | SANOFI ADR REP 1 1/2 ORD | $0 | 0.00% | 0 | Exited |
| 14 | SOXX | TLT Oct3 100.0 C | $0 | 0.00% | 0 | Exited |
| 15 | SPY | SPY Nov3 400.0 P | $0 | 0.00% | 0 | Exited |
| 16 | TCMD | TACTILE SYSTEMS TECHNOLOGY ORD | $0 | 0.00% | 0 | Exited |
| 17 | TEVA | TEVA Oct3 10.0 C | $0 | 0.00% | 0 | Exited |
| 18 | THC | TENET HEALTHCARE ORD | $0 | 0.00% | 0 | Exited |
| 19 | VTRS | VIATRIS ORD | $0 | 0.00% | 0 | Exited |
| 20 | VTRS | VTRS Oct3 11.0 C | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2023-12-31